TY  - JOUR 
AU  - Estravís Sastre, Miguel
AU  - Pérez Pazos, Jacqueline
AU  - Moreno‐Jimenez, Emma
AU  - Triviño, Juan Carlos
AU  - García Sánchez, María Asunción
AU  - Gómez‐García, Manuel
AU  - Morgado, Natalia
AU  - Ramos González, Jacinto
AU  - Gil Melcón, María
AU  - Martín García, Cristina
AU  - Muñoz Bellido, Francisco Javier
AU  - Sanz Lozano, Catalina Sofía
AU  - Isidoro García, María
AU  - Dávila González, Ignacio Jesús
PY  - 2023
SN  - 0105-4538
UR  - http://hdl.handle.net/10366/158780
AB  - [EN] Benralizumab, a monoclonal antibody targeting IL5RA, significantly improves asthma symptoms and quality of life in severe asthmatic patients. However, understanding the factors influencing treatment response remains a challenge. In this...
LA  - eng
PB  - Wiley
KW  - Benralizumab
KW  - Transcriptomics
KW  - Asthma biomarkers
KW  - CRSwNP
KW  - N-ERD
KW  - Exacerbated respiratory disease
KW  - Genetics
KW  - Allergy and Immunology
TI  - Transcriptomics reveals new regulatory mechanisms involved in benralizumab response
DO  - 10.1111/all.15869
T2  - Allergy
VL  - 78
M2  - 3023
ER  -